Clinical Trial Update: Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD) [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind study evaluating vitamin E and DHA-EE for non-alcoholic fatty liver disease, completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• DHA-EE (docosahexaenoic acid ethyl ester)
• Vitamin E (tocopherol)

Snippet

Sponsor: Naga P. Chalasani | Conditions: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Fatty Liver | Phase 2 | Status: COMPLETED | Results posted: 2023-05-25